TrialJournal of neural transmission (Vienna, Austria : 1996)2019

Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson's disease.

Nobutaka Hattori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.